- Home
- HLI vs ICLR Comparison
HLI vs ICLR Comparison
Compare HLI & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLI
- ICLR
- Stock Information
- Founded
- HLI 1972
- ICLR 1990
- Country
- HLI United States
- ICLR Ireland
- Employees
- HLI N/A
- ICLR N/A
- Industry
- HLI Investment Managers
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- HLI Finance
- ICLR Health Care
- Exchange
- HLI Nasdaq
- ICLR Nasdaq
- Market Cap
- HLI 14.1B
- ICLR 13.7B
- IPO Year
- HLI 2015
- ICLR 1998
- Fundamental
- Price
- HLI $196.99
- ICLR $174.88
- Analyst Decision
- HLI Buy
- ICLR Buy
- Analyst Count
- HLI 8
- ICLR 14
- Target Price
- HLI $202.57
- ICLR $212.62
- AVG Volume (30 Days)
- HLI 388.5K
- ICLR 984.3K
- Earning Date
- HLI 10-29-2025
- ICLR 10-22-2025
- Dividend Yield
- HLI 1.22%
- ICLR N/A
- EPS Growth
- HLI 31.68
- ICLR 13.11
- EPS
- HLI 5.94
- ICLR 9.73
- Revenue
- HLI $2,480,866,000.00
- ICLR $8,089,820,000.00
- Revenue This Year
- HLI $13.85
- ICLR N/A
- Revenue Next Year
- HLI $14.45
- ICLR $1.73
- P/E Ratio
- HLI $33.18
- ICLR $17.96
- Revenue Growth
- HLI 23.30
- ICLR N/A
- 52 Week Low
- HLI $137.99
- ICLR $125.10
- 52 Week High
- HLI $201.63
- ICLR $313.51
- Technical
- Relative Strength Index (RSI)
- HLI 54.39
- ICLR 53.80
- Support Level
- HLI $189.67
- ICLR $161.01
- Resistance Level
- HLI $201.63
- ICLR $182.67
- Average True Range (ATR)
- HLI 3.58
- ICLR 5.39
- MACD
- HLI -0.20
- ICLR -0.54
- Stochastic Oscillator
- HLI 61.20
- ICLR 64.04
About HLI Houlihan Lokey Inc.
Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments world-wide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. The Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.